Table 3. Comparison of the variables between the LSKO group postoperative 6th week results and the ESKO group results.
Parameters | LSKO group X±SD |
ESKO group X±SD |
p-value | |
---|---|---|---|---|
Pain intensity | During rest | 1.26±1.35 | 2.10±1.78 | 0.06 |
During walking | 2.10±1.69 | 4.46±2.77 | 0.001* | |
Valgus angle | 176.26±2.91 | 177.56±2.80 | 0.14 | |
Malalignment | 1.84±2.66 | 2.75±1.96 | 0.01* | |
WOMAC score | 27.92±14.24 | 33.64±12.44 | 0.14 | |
Amount of joint position sense deviation | 350 | 6.42±5.89 | 8.27±7.39 | 0.34 |
550 | 5.26±4.91 | 5.43±3.64 | 0.89 | |
700 | 6.02±4.96 | 5.89±4.89 | 0.92 | |
Cytokine | IL-6 | 161.04±30.72 | 139.04±90.68 | 0.28 |
TNF-α | 52.18±4.65 | 34.18±14.66 | <0.001* | |
IL-1β | 114.46±14.43 | 86.60±21.42 | <0.001* |
LSKO: late-stage knee osteoarthritis; ESKO: early-stage knee osteoarthritis; IL-6: interleukin 6; TNF-α: tumor necrosis factor-alpha; IL-1β: interleukin-1 beta; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; X: mean; SD: standard deviation. *Statistically significant differences (p<0.05).